CLINICAL_TRIALS
trial_result
· 2024-12-04
Clinical Trial Update: Neo-Adjuvant Immunotherapy With Nivolumab for Non Small Cell Lung Cancer Patients [Phase 2]
Summary
This update reports results from a Phase 2 trial of nivolumab as neo-adjuvant immunotherapy in non-small cell lung cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Spanish Lung Cancer Group | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-12-04